Why Healthcare Organizations & Medical Manufacturers Choose DR Labs
Medical devices are more interconnected than ever — spanning embedded components, wireless communication, cloud services, and clinical environments. Device Recon Labs provides full system end‑to‑end security testing tailored to the unique challenges and regulatory expectations of the healthcare sector.
Our experts bring decades of combined experience in cybersecurity, engineering, and medical device testing, going far beyond traditional penetration tests to evaluate the full clinical and operational attack surface.
The FDA requires that cybersecurity be treated as a critical part of overall device safety.
Device Recon Labs supports regulatory requirements for:
- Premarket submissions (including 510(k), De Novo, PMAs, PDPs, IDE, HDE and BLA)
- SPDF and QMSR alignment documentation
DR Labs test results are aligned with FDA regulatory expectations around:
- Independence and technical expertise or testers,
- Scope and duration of testing,
- Testing methods deployed, and
- Test results, findings, and observations
Partnering with Healthcare Innovators
As an organization dedicated to “securing the devices and data that saves lives,” Device Recon Labs works closely with medical device manufacturers and healthcare providers to uncover vulnerabilities before they endanger patients or delay regulatory approval.
Our mission is simple:
Make medical devices safer, more resilient, and fully prepared for regulatory cybersecurity scrutiny.
Frequently Asked Questions
FDA Cybersecurity & Penetration Testing Requirements
Ensuring strong cybersecurity isn’t optional for medical device manufacturers—it’s a core component of FDA device safety expectations. To achieve successful premarket review and 510(k) clearance, manufacturers must provide clear, credible evidence that their device can withstand realistic cyber threats. This includes penetration testing, robust documentation, and alignment with FDA cybersecurity guidance.
Penetration Testing Included in Premarket Submissions
Manufacturers must submit detailed penetration testing results as part of their cybersecurity documentation. These reports demonstrate the device’s ability to resist real‑world cyberattacks and are a required component of FDA premarket review.
Alignment with FDA Cybersecurity Guidance & SPDF
Pen testing per the FDA’s Secure Product Development Framework (SPDF) and integrate with the Quality Management System Regulation (QMSR), ensuring cybersecurity is treated as part of overall device safety and product quality.
Proper Scope, Methodology & Independent Execution
Testing must cover all relevant components—including hardware, firmware, software, network interfaces, and supporting infrastructure—and must reflect the device’s intended use environment. The FDA requires testing be conducted by qualified experts independent of the development team to ensure credible, unbiased results.
Integration with Security Risk Management
Penetration test findings must be run through your manufacturer’s security risk management process. Identified vulnerabilities must be evaluated for their impact on device safety and effectiveness, following recognized standards such as AAMI TIR57 and ISO 14971.
Evidence Required for 510(k) Clearance
For 510(k) submissions, manufacturers must provide proof of thorough vulnerability and penetration testing. The FDA expects documentation showing that security controls—such as authentication, access management, and data protection mechanisms—effectively mitigate risks before the device goes to market.
Contact Us
Unlock the Path to Faster, Safer Regulatory Clearance
Connect with our experts to identify vulnerabilities, strengthen compliance, and prepare your device for market approval.